S'abonner

Infection risk prevention following total knee arthroplasty - 11/02/10

Doi : 10.1016/j.otsr.2009.10.010 
T. Levent a, , D. Vandevelde b, J.-M. Delobelle b, P. Labourdette b, J. Létendard b, P. Lesage b, P. Lecocq c, M. Dufour a
a Infection Control Team, polyclinique du Parc, 48, rue H.-Barbusse, 59880 Saint-Saulve, France 
b Orthopedic Surgery Department, polyclinique du Parc, 48, rue H.-Barbusse, 59880 Saint-Saulve, France 
c Internal Medicine Department, Denain Hospital, 25 bis, rue J.-Jaurès, 59230 Denain, France 

Corresponding author. Tel.: +33 03 27 69 44 77; fax: +33 03 27 69 48 12.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Summary

Introduction

Implant infection is serious; prevention is mandatory, and requires assessment. The present study assessed the incidence of deep surgical-site infection (SSI) at 1 year following total knee arthroplasty (TKA) and adherence to skin preparation, antibiotic prophylaxis, screening and prevention in case of methicillin-resistant S. aureus (MRSA).

Hypothesis

Adherence to prevention measures reduces infection risk secondary to TKA.

Material and methods

A prospective study of the incidence of SSI following primary TKA was run from December 1st 2005 to December 31st 2006 in a continuous series of 364 operations in 359 patients, excluding cases of septic or aseptic revision. Each implant was followed up for 12months. Adherence to practice was assessed by independent observers. Antibiotic prophylaxis was assessed; skin preparation was scored (out of 10); MRSA was systematically screened for, and preventive measures were assessed in positive cases. Median follow-up was 12 months. Patients with less than 11months’ FU were contacted by telephone. Median age was 72years (range, 45–92years). Eighty-seven percent of patients had ASA scores of 2; 14% were diabetic, and 42% obese. Mean surgery time was 70min (range, 30–164min). Among the implants, 81.5% were cemented. Eighty-six percent of operations had NNIS scores of 0. Infection risk linked to theater environment and teams was under control.

Results

Fourteen patients were lost to follow-up and excluded from analysis. The incidence of infection was 1.4% (n=5/350) (95% CI [0.41–3.22]). Three of the infections were early (≤1month), and two were polymicrobial. Antibiotic prophylaxis was implemented correctly in 99% of cases, with skin preparation scores of 8.75 in 61% of cases and of 10 in 39%. Among the pattients, 2.5% were MRSA-positive, none of whom developed infection. Infection prevention measures were applied in only half of the MRSA-positive cases. No MRSA-positive patients developed SSI.

Discussion

SSI incidence in the present series was low, but certainly underestimated. Assessment found good implementation of infection prevention protocols, with SSI occurring randomly with regard to adherence parameters (antibiotic prophylaxis, skin preparation, MRSA status).

Conclusion

Our hypothesis could not be confirmed. The study was mandatory for a health-care institution, and indispensable from a legal standpoint.

Level of Evidence

Level IV. Prospective prognostic study.

Le texte complet de cet article est disponible en PDF.

Keywords : Guidelines, Infection control, Quality program, Total knee replacement, Practice


Plan


© 2009  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 96 - N° 1

P. 49-56 - février 2010 Retour au numéro
Article précédent Article précédent
  • Type C periprosthetic fractures treated with locking plate fixation with a mean follow up of 2.5 years
  • M. Ehlinger, P. Adam, T. Moser, D. Delpin, F. Bonnomet
| Article suivant Article suivant
  • Knee arthrodesis using a vascularised fibular rotatory graft after tumor resection
  • H. Nouri, M.H. Meherzi, M. Jenzeri, M. Daghfous, R. Hdidane, K. Zehi, L. Tarhouni, S. Karray, S. Baccari, M. Mestiri, M. Zouari

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.